flutamide sold brand name eulexin among others nonsteroidal antiandrogen nsaa used primarily treat prostate also used treatment androgendependent conditions like acne excessive hair growth high androgen levels taken mouth usually three times per side effects men include breast tenderness enlargement feminization sexual dysfunction hot flashes conversely medication fewer side effects bettertolerated women common side effect dry skin diarrhea elevated liver enzymes occur sexes rarely flutamide cause liver damage lung disease sensitivity light elevated methemoglobin elevated sulfhemoglobin deficient numerous cases liver failure death reported limited use flutamide acts selective antagonist androgen receptor ar competing androgens like testosterone dihydrotestosterone dht binding ars tissues like prostate gland prevents effects stops stimulating prostate cancer cells grow flutamide prodrug active form flutamide active form stay body relatively short time makes necessary take flutamide multiple times per daycitation needed flutamide first described first introduced medical use became available united states medication largely replaced newer improved nsaas namely bicalutamide enzalutamide due better efficacy tolerability safety dosing frequency per day relatively world health organizations list essential gnrh released hypothalamus pulsatile fashion causes anterior pituitary gland release luteinizing hormone lh folliclestimulating hormone fsh lh stimulates testes produce testosterone metabolized dht enzyme needed dht significantly smaller extent testosterone stimulate prostate cancer cells grow therefore blocking androgens provide powerful treatment prostate cancer especially metastatic disease normally administered gnrh analogues leuprorelin cetrorelix although gnrh agonists stimulate receptors gnrh since present continuously pulsatile manner serve inhibit pituitary gland therefore block whole chain however initially cause surge activity solely theoretical risk may cause cancer flare flutamide initially used beginning gnrh agonist therapy block surge nsaas continue use contrast gnrh agonists gnrh antagonists dont cause initial androgen surge gradually replacing gnrh agonists clinical usecitation needed studies investigate benefit adding antiandrogen surgical orchiectomy continued use gnrh analogue combined androgen blockade cab adding antiandrogens orchiectomy showed benefit small benefit shown adding antiandrogens gnrh analoguescitation needed unfortunately therapies lower testosterone levels orchiectomy gnrh analogue administration also significant side effects compared therapies treatment antiandrogens exhibits fewer hot flashes less effect libido less muscle wasting fewer personality changes less bone loss however antiandrogen therapy alone less effective surgery nevertheless given advanced age many prostate cancer well features many men may choose antiandrogen therapy alone better quality flutamide found similarly effective treatment prostate cancer bicalutamide although indications inferior efficacy including greater compensatory increases testosterone levels greater reductions psa levels bicalutamide medication dosage mgday mg three times daily also found equivalent effectiveness mgday oral cyproterone acetate monotherapy treatment prostate cancer largescale clinical trial patients though side effect toxicity profiles including gynecomastia diarrhea nausea loss appetite liver disturbances regarded considerably worse cyproterone dosage mgday flutamide mgthree times day roughly equivalent terms effectiveness mgday bicalutamide used antiandrogen component combined androgen blockade treatment advanced prostate flutamide used prevent effects testosterone flare start gnrh agonist therapy men prostate citations combination flutamide estrogen ethinylestradiol sulfonate used form combined androgen blockade alternative combination flutamide surgical medical flutamide researched used extensively treatment androgendependent skin hair conditions women including acne seborrhea hirsutism scalp hair loss well hyperandrogenism eg polycystic ovary syndrome congenital adrenal hyperplasia effective improving symptoms conditions dosages used lower used treatment prostate cancer although flutamide continues used indications use recent years limited due risk potentially fatal hepatotoxicity longer recommended first secondline related nsaa bicalutamide also found effective treatment hirsutism women appears comparable effectiveness far lower small risk hepatotoxicity aside risk liver toxicity besides nonsteroidal antiandrogens said flutamide likely best typically used antiandrogen medication treatment androgendependent symptoms related high effectiveness minimal side flutamide found effective treatment acne seborrhea women number longterm study women acne also seborrhea verylowdose flutamide alone combination oral contraceptive caused marked decrease acne seborrhea months treatment maximal effect year treatment benefits maintained years study women reported satisfaction control acne another study flutamide decreased acne seborrhea scores contrast spironolactone decreased symptoms time period suggesting superior effectiveness flutamide flutamide general found reduce symptoms acne much even low doses several studies showing complete acne flutamide found effective treatment hirsutism excessive bodyfacial hair growth numerous possesses moderate effectiveness indication overall quality evidence considered medication shows equivalent superior effectiveness antiandrogens including spironolactone cyproterone acetate finasteride treatment hirsutism although relatively high risk hepatotoxicity makes unfavorable compared used treat hirsutism dosages ranging mgday study found multiple dosages flutamide significantly reduced hirsutism women polycystic ovary syndrome significant differences effectiveness dosages mgday mgday addition study found combination mgday flutamide finasteride effective mgday flutamide alone treatment findings support use flutamide lower doses hirsutism without loss effectiveness may help lower risk however risk found remain even low flutamide found effective treatment female pattern hair loss number one study pre postmenopausal women flutamide alone combination oral contraceptive produced marked decrease hair loss scores year treatment maximum effect years treatment benefits maintained another small study flutamide oral contraceptive medication caused increase cosmetically acceptance hair density women diffuse scalp hair comparative study flutamide significantly improved scalp hair growth reduction ludwig scores hyperandrogenic women year treatment whereas cyproterone acetate finasteride flutamide used case reports decrease frequency spontaneous orgasms instance men postorgasmic illness flutamide available form mg oral capsules mg oral side effects flutamide sexdependent men variety side effects related androgen deprivation may occur common gynecomastia breast others include hot flashes decreased muscle mass decreased bone mass associated increased risk fractures sexual dysfunction including reduced libido erectile women flutamide generally relatively well tolerated interfere common side effect flutamide women dry skin attributed reduction androgenmediated sebum general side effects may occur either sex include dizziness lack appetite gastrointestinal side effects nausea vomiting diarrhea greenishbluish discoloration hepatic flutamide pure antiandrogen unlike steroidal antiandrogens like cyproterone acetate megestrol acetate additionally possess progestogenic activity appear risk cardiovascular side effects eg thromboembolism fluid flutamide monotherapy causes gynecomastia men also produces breast however cases gynecomastia nsaas including flutamide mild tamoxifen selective estrogen receptor modulator serm predominantly antiestrogenic actions counteract flutamideinduced gynecomastia breast pain mencitation needed diarrhea common sometimes severe flutamide comparative trial combined androgen blockade prostate cancer rate diarrhea flutamide moreover flutamidetreated patients discontinued medication due diarrhea whereas bicalutamidetreated patients case antiandrogen monotherapy prostate cancer rates diarrhea flutamide bicalutamide contrast diarrhea rates nausea vomiting similar among three although rare flutamide associated severe hepatotoxicity cases severe cholestatic hepatitis reported continued case reports since including liver transplants review literature found cases serious hepatotoxicity women treated flutamide including liver transplantations based number prescriptions written number cases reported medwatch database rate serious hepatotoxicity associated flutamide treatment estimated approximately per however research suggested true incidence significant hepatotoxicity flutamide may much greater high flutamide also associated liver enzyme elevations patients although marked elevations liver enzymes times upper normal limit occur risk hepatotoxicity flutamide much higher nilutamide lower doses medication appear possibly reduced still significant liver function monitored regularly liver function tests flutamide addition due high risk serious hepatotoxicity flutamide used absence serious mechanism action flutamideinduced hepatotoxicity thought due mitochondrial specifically flutamide particularly major metabolite hydroxyflutamide inhibit enzymes mitochondrial electron transport chain hepatocytes including respiratory complexes nadh ubiquinone oxidoreductase ii succinate dehydrogenase v atp synthase thereby reduce cellular respiration via atp depletion hence decrease cell inhibition taurocholate bile acid efflux also implicated flutamideinduced contrast flutamide hydroxyflutamide severely compromise hepatocyte cellular respiration vitro bicalutamide significantly concentrations regarded thought nitroaromatic group flutamide hydroxyflutamide enhance mitochondrial toxicity bicalutamide contrast possesses cyano group place nitro moiety greatly reducing potential hepatotoxicity flutamide appears depend hydrolysis flutamide catalyzed arylacetamide deacetalyse analogous hepatotoxicity occurs withdrawn paracetamol acetominophenrelated medication accordance combination paracetamol acetaminophen flutamide appears result additive synergistic hepatotoxicity indicating potential drug hepatotoxicity flutamide may crossreactive cyproterone flutamide also associated interstitial pneumonitis progress pulmonary incidence interstitial pneumonitis flutamide found per large clinical cohort prostate cancer variety case reports associated flutamide flutamide associated several case reports bicalutamide appear share risk flutamide also associated reports sulfhemoglobinemia available endocrinedisrupting compounds looked flutamide notable effect anogenital distance flutamide acts selective competitive silent antagonist androgen receptor active form hydroxyflutamide higher affinity ar flutamide hence much potent ar antagonist however high concentrations unlike flutamide hydroxyflutamide able weakly activate flutamide far lower affinity ar steroidal antiandrogens like spironolactone cyproterone acetate relatively weak antiandrogen terms potency weight large dosages flutamide used appear compensate accordance selectivity ar flutamide interact progesterone estrogen glucocorticoid mineralocorticoid possesses intrinsic progestogenic estrogenic glucocorticoid antigonadotropic however indirect estrogenic effects via increased levels estradiol secondary ar blockade involved gynecomastia produce flutamide estrogenic progestogenic antigonadotropic activity medication cause menstrual irregularities contrast steroidal antiandrogens like spironolactone cyproterone similarly nilutamide bicalutamide enzalutamide flutamide crosses barrier exerts central antiandrogen flutamide found equal slightly potent cyproterone acetate substantially potent spironolactone antiandrogen spite fact hydroxyflutamide order lower affinity ar relative cyproterone hydroxyflutamide shows lower affinity rat human ar addition whereas bicalutamide elimination halflife around days hydroxyflutamide elimination halflife hours roughly accordance dosages mgday bicalutamide mgday flutamide difference circulating levels flutamide steadystate found approximately lower moreover whereas flutamide dosage found produce reduction prostatespecific antigen levels men prostate cancer fall demonstrated dosage accordance mgday bicalutamide found possess equivalent superior effectiveness mgday flutamide large clinical trial prostate also bicalutamide shown potent flutamide rats potent flutamide taken together flutamide appears considerably less potent efficacious antiandrogen doseranging studies flutamide men benign prostatic hyperplasia prostate cancer alone combination gnrh agonist flutamide increases testosterone levels gonadally intact male flutamide hydroxyflutamide found vitro inhibit enzyme required biosynthesis accordance flutamide found slightly significantly lower androgen levels gnrh analoguetreated male prostate cancer women polycystic ovary directly comparative study flutamide monotherapy mg daily versus bicalutamide monotherapy mg daily japanese men prostate cancer weeks treatment flutamide decreased dehydroepiandrosterone dhea levels bicalutamide increased flutamide weak inhibitor androgen however clinical significance action may limited flutamide given without gnrh analogue noncastrated men medication markedly elevates testosterone levels high normal male range via prevention ar activationmediated negative feedback axis flutamide identified agonist aryl hydrocarbon may involved hepatotoxicity absorption flutamide complete upon oral food effect bioavailability steadystate levels hydroxyflutamide active form flutamide achieved days levels hydroxyflutamide approximately higher flutamide plasma protein binding flutamide hydroxyflutamide high flutamide metabolite hydroxyflutamide known transported multidrug resistanceassociated protein flutamide metabolized via αhydroxylation liver firstpass main metabolite hydroxyflutamide accounts oral dose flutamide one hour least five minor flutamide least inactive metabolites total including flutamide excreted various forms urine primary form flutamide hydroxyflutamide elimination halflives hours hours adults however halflife hydroxyflutamide extended hours single dose hours steady state elderly elimination halflives flutamide hydroxyflutamide regarded short allow oncedaily dosing reason flutamide instead administered three times daily contrast newer nsaas nilutamide bicalutamide enzalutamide much longer allows oncedaily administration unlike hormones competes flutamide steroid rather substituted anilide hence described nonsteroidal order distinguish older steroidal antiandrogens cyproterone acetate megestrol acetate reaction isobutanoyl chloride presence triethylamine flutamide first synthesized neri colleagues schering plough originally synthesized bacteriostatic agent subsequently serendipitously found possess antiandrogen code name flutamide development clinical research medication began first marketed specifically chile brand name drogenil west germany brand name flutamide introduced united states specifically approved us food drug administration treatment metastatic prostate cancer combination gonadotropinreleasing hormone gnrh medication first studied treatment hirsutism women first pure antiandrogen studied treatment flutamide first nsaa introduced followed nilutamide bicalutamide flutamide generic name drug inntooltip international nonproprietary name usantooltip united states adopted name bantooltip british approved name dcftooltip dénomination commune française jantooltip japanese accepted names latin german spanish flutamidum flutamid flutamida medication also referred name brand names flutamide include included cebatrol cytomid drogenil etaconil eulexin flucinom flumid flutacan flutamid flutamida flutamin flutan flutaplex flutasin fugerel profamid sebatrol among flutamide marketed widely throughout world including united states canada europe australia new zealand south africa central south america east southeast asia india middle combination estrogen flutamide form combined androgen blockade treatment prostate cancer flutamide studied treatment benign prostatic hyperplasia bph enlarged prostate men several clinical found reduce prostate volume comparable reduction achieved inhibitor unfortunately associated side effects studies including gynecomastia breast tenderness patients gastrointestinal disturbances nausea diarrhea flatulence hepatotoxicity although sexual function including libido erectile potency flutamide studied treatment advanced breast cancer two phase ii clinical trials found total patients three shortterm responses however patients studies selected irrespective ar ertooltip estrogen receptor prtooltip progesterone receptor status flutamide studied treatment bulimia nervosa flutamide found effective treatment disorder ocd men comorbid tourettes syndrome one small randomized controlled conversely ineffective patients ocd another research necessary determine whether flutamide effective treatment httpsenwikipediaorgwikiflutamide